24 results on '"Patel, Sanjay S."'
Search Results
2. Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML
3. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City
4. Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment
5. PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
6. The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4–positive T cells that are PD-1–negative
7. Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children
8. MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications
9. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
10. Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms
11. High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML
12. Implications of the tumor immune microenvironment for staging and therapeutics
13. Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice
14. Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children
15. NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype
16. Under AI’s lens: spotting mutations visually
17. PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation
18. PD-1 Blockade for Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation
19. Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies
20. Reduced Pain Intensity and Opioid Consumption for 96 Hours after Abdominoplasty after Administration of HTX-011, a Proprietary, Extended-Release Combination of Bupivacaine and Meloxicam
21. HTX-011, a Proprietary, Extended-Release Combination of Bupivacaine and Meloxicam, Reduces Acute Postoperative Pain Intensity and Opioid Consumption after Bunionectomy: Results From an Interim Analysis
22. Leukemic-phase progression of aleukemic mast cell leukemia
23. Neuromuscular blocking activity of cyclic and acyclic bis-quaternary ammonium analogues of mivacurium chloride in the cat
24. Neuromuscular blocking activity of bis-4-benzyltetrahydroisoquinolinium esters in the cat
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.